Search
Close this search box.

Ascendiant Capital Markets, LLC

Ascendiant News

See Our Impact

Need capital to meet your growth plans? Get in touch with our team today!

Ascendiant Capital Markets LLC’s At-the-Market (ATM) Offering for Verb Technology Company, Inc. (Nasdaq: VERB) Increased to $12,765,000

JUPITER, Florida – May 13, 2024 — Ascendiant Capital Markets LLC (“Ascendiant”) announced today the filing of an amendment to its At-the-Market (ATM) Offering for Verb Technology Company, Inc. (Nasdaq: VERB) of Las Vegas, Nevada, increasing the amount to $12,765,000.

Ascendiant is serving as Sole Sales Agent on the financing transaction. To view the announcement, click here.

Share this post with your friends:

Facebook
Twitter
LinkedIn

Want to stay up-to-date with the latest at Ascendiant? Subscribe to our mailing list!

Newsletter Form (#2)

See other recent news

May 13, 2024
Ascendiant Capital Markets LLC’s At-the-Market (ATM) Offering for Verb Technology Company, Inc. (Nasdaq: VERB) Increased to $12,765,000
May 6, 2024
Ascendiant Capital Markets LLC Serves as Sole Sales Agent on $20,000,000 At-the-Market (ATM) Offering for Allarity Therapeutics, Inc. (Nasdaq: ALLR)
April 29, 2024
Ascendiant Capital Markets LLC Serves as Sole Sales Agent on $8,000,000 At-the-Market (ATM) Offering for Air T, Inc. (Nasdaq: AIRT) and Air T Funding (Nasdaq: AIRTP)
April 22, 2024
Ascendiant Initiates Equity Research Coverage on Cyclo Therapeutics, Inc. (Nasdaq: CYTH)
April 8, 2024
Ascendiant Initiates Equity Research Coverage on Banzai International, Inc. (Nasdaq: BNZI)
March 29, 2024
Ascendiant Capital Markets LLC’s At-the-Market (ATM) Offering for Verb Technology Company, Inc. (Nasdaq: VERB) Increased to $9,010,000
March 25, 2024
Ascendiant Capital Markets LLC Serves as Sole Sales Agent on $6,260,000 At-the-Market (ATM) Offering For Verb Technology Company, Inc. (Nasdaq: VERB)
March 20, 2024
Ascendiant Capital Markets LLC Serves as Sole Sales Agent on $947,000 At-the-Market (ATM) Offering for Allarity Therapeutics, Inc. (Nasdaq: ALLR)
February 26, 2024
Ascendiant Initiates Equity Research Coverage on LiqTech International, Inc. (Nasdaq: LIQT)
February 22, 2024
Ascendiant Capital Markets LLC Serves as Sole Placement Agent on $3,300,000 Private Placement for AIM ImmunoTech Inc. (NYSE American: AIM)
February 15, 2024
Ascendiant Capital Markets LLC Serves as Sole Sales Agent on $6,200,000 At-the-Market (ATM) Offering for ENDRA Life Sciences Inc. (Nasdaq: NDRA)
February 12, 2024
Ascendiant Initiates Equity Research Coverage on IGC Pharma, Inc. (NYSE American: IGC)